Dismiss Modal

Provider Referrals (Test)


A provider holds a tablet while visiting a patient

Send a Referral

We are committed to making the referral process as seamless as possible for you and your patients. Soon, physicians will have multiple ways to refer patients to ArrIVe Infusion Therapy, ensuring timely access to high-quality infusion care.

Referral Process Tip Sheet for Providers

 

How to Refer

Providers can submit referrals through one of the following methods:

  1. Online Referral Form: Complete a secure online referral form and submit it directly through our website.
     
  2. Phone Referral: Call our referral team at 810-844-7373 to provide patient details and initiate the referral process.
     
  3. Fax Referral: Download a referral form and fax your submission. For all referrals please include: demographics, insurance information, lab results, current medications, and recent visit notes.
     
  4. Epic Referral: Providers with access to Epic will be able to submit referrals directly through Epic. Look for Brighton Department Name: SJVPB ARRIVE INFUSION CENTER

Thank you for your partnership in providing exceptional infusion care. We look forward to serving your patients soon!

 

Brighton Referral Forms

 


Abatacept (Orencia)


Agalsidase beta (Fabrazyme®)


Alemtuzumab (Lemtrada®)


Alpha1-proteinase inhibitor (Prolastin-C®)


Anifrolumab-fnia (Saphnelo)


Antimicrobial Therapy


Belatacept (Nulojix)


Belimumab (Benlysta)


Benralizumab (Fasenra)


Certolizumab Pegol (Cimzia)


Cyanocobalamin (Vitamin B-12)


Darbepoetin (Aranesp)


Denosumab (Prolia)


Denosumab (Xgeva)


Desmopressin (DDAVP)


Eculizumab (Soliris®)


Efgartigimod alpha-fcab (Vygart)


Epoetin Alfa (Epogen, Procrit, Retacrit)


Eptinezumab-jjmr (Vypeti)


General Order Form


Golimumab (Simponi)


IGIV


Inclisiran (Leqvio)


Infliximab (Remicaid) or Biosimilar


Iron Infusion


IV Hydration and Electrolytes


Leuprolide (Eligard)


Mepolizumab (Nucala)


Methylprednisolone (Solu-Medrol)


Natalizumab (Tysabri)


Ocrelizumab (Ocrevus)


Octreotide Depot (Sandostatin LAR)


Omalizmab (Xolair)


Oritavancin (Orbactiv)


Pegloticase (Krystexxa®)


Rabies Vaccine (Imovax, Rabavert)


Ravulizumab (Ultomiris®)


Reslizumab (Cinqair)


Rho (D) Immune Globulin (Rhophylac)


Risankizumab-rzaa (Skyrizi)


Rituximab (Rituxn) or Biosimilar


Romosozumab-aqqg (Evenity)


Rozanolixizumab-noli (Rystiggo®)


Secukinumab (Cosentyx)


Spesolimab-sbzo (Spevigo)


Tezepelumab (Tezspire)


Tildrakizumab-asmn (Ilumya®)


Tocilizumab (Actemra)


Ublituximab-xiiy (Briumvi)


Ustekinumab (Stelera)


Vedolizumab (Entyvio)


Zoledronic Acid (Relcast, Zometa)